stopping glp 1 Two Years After GLP-1s, Most Patients Sustain at Least Some Weight Loss In the original clinical trials

Semaglutide and Tirzepatide in Clinical Research Newer GLP-1 medications, especially semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound), have been the subject of significant clinical research

It is not medication-specific medical advice

Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes

10.1093/eurheartj/ehz425 3

This protein-first approach helps create a stable, long-lasting sense of fullness and prevents the rapid blood sugar spikes that can often lead to a binge-restrict cycle

What's Missing in Standard Care Most GLP-1 prescribers overlook critical factors for PCOS patients: Proper dosing for hormone balance, not just weight loss : The optimal dose for PCOS may differ from general weight loss protocols